tiprankstipranks
Altimmune reports Q4 EPS (54c), consensus (43c)
PremiumThe FlyAltimmune reports Q4 EPS (54c), consensus (43c)
23d ago
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
23d ago
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
25d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Altimmune down 16% after Kerrisdale short report
PremiumThe FlyAltimmune down 16% after Kerrisdale short report
2M ago
Short Altimmune ahead of pemvidutide Phase 3 ‘bomb,’ says Kerrisdale
PremiumThe Fly
Short Altimmune ahead of pemvidutide Phase 3 ‘bomb,’ says Kerrisdale
2M ago
Kerrisdale Capital says short Altimmune, says only drug ‘going to bomb’
PremiumThe Fly
Kerrisdale Capital says short Altimmune, says only drug ‘going to bomb’
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100